Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T14:49:53.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:51:34.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T17:40:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T18:18:30.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, indicating access to the study record is blocked.
    Difference
    22%
    Check dated 2026-09-19T22:28:52.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.5 to v3.6.6, reflecting a software update applied to the page.
    Difference
    0.0%
    Check dated 2026-08-29T19:09:55.000Z thumbnail image

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.